Literature DB >> 17875940

Loss of Emi1-dependent anaphase-promoting complex/cyclosome inhibition deregulates E2F target expression and elicits DNA damage-induced senescence.

Emmy W Verschuren1, Kenneth H Ban, Marilyn A Masek, Norman L Lehman, Peter K Jackson.   

Abstract

Expression of the anaphase-promoting complex/cyclosome (APC/C) inhibitor Emi1 is required for the accumulation of APC/C substrates crucial for DNA synthesis and mitotic entry. We show that in vivo Emi1 expression correlates with the proliferative status of the cellular compartment and that cells lacking Emi1 undergo cellular senescence. Emi1 depletion leads to strong decreases in E2F target mRNA and APC/C substrate protein abundances. However, cyclin E mRNA and cyclin E protein levels and associated kinase activities are increased. Cells lacking Emi1 undergo DNA damage, likely explained by replication stress upon deregulated cyclin E- and A-associated kinase activities. Inhibition of ATM kinase prevents induction of senescence, implying that senescence is a consequence of DNA damage. Surprisingly, no senescence or no extensive amount of senescence is evident upon depletion of the Emi1-stabilizing factor Evi5 or Pin1, respectively. Our data suggest that maintenance of a protein stabilization/mRNA expression positive-feedback circuit fueled by Emi1 is required for accurate cell cycle progression, maintenance of DNA integrity, and prevention of cellular senescence.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17875940      PMCID: PMC2169152          DOI: 10.1128/MCB.00908-07

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  56 in total

1.  Intra-S-phase checkpoint activation by direct CDK2 inhibition.

Authors:  Yonghong Zhu; Carmen Alvarez; Ronald Doll; Hirokazu Kurata; Xiao Min Schebye; David Parry; Emma Lees
Journal:  Mol Cell Biol       Date:  2004-07       Impact factor: 4.272

2.  Control of the SCF(Skp2-Cks1) ubiquitin ligase by the APC/C(Cdh1) ubiquitin ligase.

Authors:  Tarig Bashir; N Valerio Dorrello; Virginia Amador; Daniele Guardavaccaro; Michele Pagano
Journal:  Nature       Date:  2004-03-11       Impact factor: 49.962

3.  A biomarker that identifies senescent human cells in culture and in aging skin in vivo.

Authors:  G P Dimri; X Lee; G Basile; M Acosta; G Scott; C Roskelley; E E Medrano; M Linskens; I Rubelj; O Pereira-Smith
Journal:  Proc Natl Acad Sci U S A       Date:  1995-09-26       Impact factor: 11.205

4.  Regulation of the cyclin E gene by transcription factor E2F1.

Authors:  K Ohtani; J DeGregori; J R Nevins
Journal:  Proc Natl Acad Sci U S A       Date:  1995-12-19       Impact factor: 11.205

5.  Negative regulation of the growth-promoting transcription factor E2F-1 by a stably bound cyclin A-dependent protein kinase.

Authors:  W Krek; M E Ewen; S Shirodkar; Z Arany; W G Kaelin; D M Livingston
Journal:  Cell       Date:  1994-07-15       Impact factor: 41.582

6.  Activation of cyclin E/CDK2 is coupled to site-specific autophosphorylation and ubiquitin-dependent degradation of cyclin E.

Authors:  K A Won; S I Reed
Journal:  EMBO J       Date:  1996-08-15       Impact factor: 11.598

7.  Role of Polo-like kinase in the degradation of early mitotic inhibitor 1, a regulator of the anaphase promoting complex/cyclosome.

Authors:  Yakir Moshe; Jérôme Boulaire; Michele Pagano; Avram Hershko
Journal:  Proc Natl Acad Sci U S A       Date:  2004-05-17       Impact factor: 11.205

8.  Rereplication by depletion of geminin is seen regardless of p53 status and activates a G2/M checkpoint.

Authors:  Wenge Zhu; Yuefeng Chen; Anindya Dutta
Journal:  Mol Cell Biol       Date:  2004-08       Impact factor: 4.272

9.  Deregulation of cyclin E in human cells interferes with prereplication complex assembly.

Authors:  Susanna Ekholm-Reed; Juan Méndez; Donato Tedesco; Anders Zetterberg; Bruce Stillman; Steven I Reed
Journal:  J Cell Biol       Date:  2004-06-14       Impact factor: 10.539

10.  Loss of Geminin induces rereplication in the presence of functional p53.

Authors:  Marina Melixetian; Andrea Ballabeni; Laura Masiero; Patrizia Gasparini; Raffaella Zamponi; Jiri Bartek; Jiri Lukas; Kristian Helin
Journal:  J Cell Biol       Date:  2004-05-24       Impact factor: 10.539

View more
  21 in total

1.  Arabidopsis ULTRAVIOLET-B-INSENSITIVE4 maintains cell division activity by temporal inhibition of the anaphase-promoting complex/cyclosome.

Authors:  Jefri Heyman; Hilde Van den Daele; Kevin De Wit; Véronique Boudolf; Barbara Berckmans; Aurine Verkest; Claire Lessa Alvim Kamei; Geert De Jaeger; Csaba Koncz; Lieven De Veylder
Journal:  Plant Cell       Date:  2011-12-13       Impact factor: 11.277

Review 2.  Insights into phosphorylation-dependent mechanisms regulating USP1 protein stability during the cell cycle.

Authors:  Xiomaris M Cotto-Rios; Mathew J K Jones; Tony T Huang
Journal:  Cell Cycle       Date:  2011-12-01       Impact factor: 4.534

3.  Characterization of harpy/Rca1/emi1 mutants: patterning in the absence of cell division.

Authors:  Bruce B Riley; Elly M Sweet; Rebecca Heck; Adrienne Evans; Karen N McFarland; Rachel M Warga; Donald A Kane
Journal:  Dev Dyn       Date:  2010-03       Impact factor: 3.780

4.  NEDD8-targeting drug MLN4924 elicits DNA rereplication by stabilizing Cdt1 in S phase, triggering checkpoint activation, apoptosis, and senescence in cancer cells.

Authors:  Jie Jessie Lin; Michael A Milhollen; Peter G Smith; Usha Narayanan; Anindya Dutta
Journal:  Cancer Res       Date:  2010-12-15       Impact factor: 12.701

Review 5.  The ubiquitin proteasome system in neuropathology.

Authors:  Norman L Lehman
Journal:  Acta Neuropathol       Date:  2009-07-14       Impact factor: 17.088

6.  Emi1 maintains genomic integrity during zebrafish embryogenesis and cooperates with p53 in tumor suppression.

Authors:  Jennifer Rhodes; Adam Amsterdam; Takaomi Sanda; Lisa A Moreau; Keith McKenna; Stefan Heinrichs; Neil J Ganem; Karen W Ho; Donna S Neuberg; Adam Johnston; Yebin Ahn; Jeffery L Kutok; Robert Hromas; Justin Wray; Charles Lee; Carly Murphy; Ina Radtke; James R Downing; Mark D Fleming; Laura E MacConaill; James F Amatruda; Alejandro Gutierrez; Ilene Galinsky; Richard M Stone; Eric A Ross; David S Pellman; John P Kanki; A Thomas Look
Journal:  Mol Cell Biol       Date:  2009-08-24       Impact factor: 4.272

7.  In vivo overexpression of Emi1 promotes chromosome instability and tumorigenesis.

Authors:  S Vaidyanathan; K Cato; L Tang; S Pavey; N K Haass; B G Gabrielli; P H G Duijf
Journal:  Oncogene       Date:  2016-04-11       Impact factor: 9.867

8.  Selective enhancing effect of early mitotic inhibitor 1 (Emi1) depletion on the sensitivity of doxorubicin or X-ray treatment in human cancer cells.

Authors:  Natsumi Shimizu; Nakako Izumi Nakajima; Takaaki Tsunematsu; Ikuko Ogawa; Hidehiko Kawai; Ryoichi Hirayama; Akira Fujimori; Akiko Yamada; Ryuichi Okayasu; Naozumi Ishimaru; Takashi Takata; Yasusei Kudo
Journal:  J Biol Chem       Date:  2013-05-03       Impact factor: 5.157

Review 9.  Replication licensing and cancer--a fatal entanglement?

Authors:  J Julian Blow; Peter J Gillespie
Journal:  Nat Rev Cancer       Date:  2008-08-29       Impact factor: 60.716

10.  Rereplication in emi1-deficient zebrafish embryos occurs through a Cdh1-mediated pathway.

Authors:  Mara E Robu; Yong Zhang; Jennifer Rhodes
Journal:  PLoS One       Date:  2012-10-17       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.